Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Forbrig

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Neuro-Oncology Advances|January 7, 2026
A novel vascular model yields increased MR perfusion metrics compared to conventional dynamic susceptibility contrast algorithms in untreated glioblastomaJonas Reis, Robert Stahl, Katharina J Müller, et al.
Journal of Neuro-Oncology|July 23, 2025
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3Jens Blobner, Viktoria Ruf, Jonathan Weller, et al.
Clinical and Translational Radiation Oncology|January 19, 2023
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysisRaphael Bodensohn, Simone Werner, Jonas Reis, et al.
Frontiers in Oncology|January 6, 2023
The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicineSophie Katzendobler, Anna Do, Jonathan Weller, et al.
Cancers|April 30, 2021
Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma RecurrencesStefanie Lietke, Michael Schmutzer, Christoph Schwartz, et al.
Neuro-Oncology Advances|October 27, 2021
Multimodal therapy of cavernous sinus meningioma: Impact of surgery and <sup>68</sup>Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcomeIndrawati Hadi, Annamaria Biczok, Nicole Terpolilli, et al.
Neuro-Oncology|November 19, 2024
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessmentsKatharina J Müller, Robert Forbrig, Jonas Reis, et al.
Hemasphere|February 22, 2021
Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-CellsPhilipp Karschnia, Felix Strübing, Nico Teske, et al.
Clinical Neuroradiology|June 7, 2021
Late Thrombectomy in Clinical Practice : Retrospective Application of DAWN/DEFUSE3 Criteria within the German Stroke RegistryMoriz Herzberg, Korbinian Scherling, Robert Stahl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2025
Severe course of tick-borne encephalitis (TBE) in a patient with relapsing multiple sclerosis (MS) treated with ocrelizumabJonathan A Gernert, Matthias Klein, Florian Schöberl, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Neuro-Oncology Advances|January 7, 2026
A novel vascular model yields increased MR perfusion metrics compared to conventional dynamic susceptibility contrast algorithms in untreated glioblastomaJonas Reis, Robert Stahl, Katharina J Müller, et al.
Journal of Neuro-Oncology|July 23, 2025
Clinical and neuropathological criteria for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3Jens Blobner, Viktoria Ruf, Jonathan Weller, et al.
Clinical and Translational Radiation Oncology|January 19, 2023
Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysisRaphael Bodensohn, Simone Werner, Jonas Reis, et al.
Frontiers in Oncology|January 6, 2023
The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicineSophie Katzendobler, Anna Do, Jonathan Weller, et al.
Cancers|April 30, 2021
Interstitial Photodynamic Therapy Using 5-ALA for Malignant Glioma RecurrencesStefanie Lietke, Michael Schmutzer, Christoph Schwartz, et al.
Neuro-Oncology Advances|October 27, 2021
Multimodal therapy of cavernous sinus meningioma: Impact of surgery and <sup>68</sup>Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcomeIndrawati Hadi, Annamaria Biczok, Nicole Terpolilli, et al.
Neuro-Oncology|November 19, 2024
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessmentsKatharina J Müller, Robert Forbrig, Jonas Reis, et al.
Hemasphere|February 22, 2021
Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-CellsPhilipp Karschnia, Felix Strübing, Nico Teske, et al.
Clinical Neuroradiology|June 7, 2021
Late Thrombectomy in Clinical Practice : Retrospective Application of DAWN/DEFUSE3 Criteria within the German Stroke RegistryMoriz Herzberg, Korbinian Scherling, Robert Stahl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2025
Severe course of tick-borne encephalitis (TBE) in a patient with relapsing multiple sclerosis (MS) treated with ocrelizumabJonathan A Gernert, Matthias Klein, Florian Schöberl, et al.
Pageof 11